Navigation Links
Excela Health Selects Allscripts Electronic Health Record for Physicians
Date:1/8/2009

rics, the web-based solution enhances the way individual physicians practice medicine and enables more effective disease management, health maintenance, and care planning.

Allscripts Enterprise was rated the No. 1 Electronic Health Record in the mid-size physician market by the prestigious research group KLAS, the "Consumer Reports" of healthcare, in the 2008 Top 20 Best in KLAS Awards: Software & Professional Services report.

Excela Health will also offer Allscripts ePrescribe(TM), a stand-alone Web-based electronic prescribing solution, at no cost to all physicians affiliated with its hospitals to promote safer prescribing and to encourage physicians to adopt automated solutions.

Allscripts ePrescribe, designed to appeal to physicians in solo practice or small groups, requires no download, no new hardware, and minimal training. All prescriptions are instantly checked for drug-to-drug, drug-allergy and other potentially harmful interactions, and users receive real-time notification of insurance formulary status from leading payers, plans and pharmacy benefit managers.

In addition to deploying Allscripts for its employed physician group, Excela has partnered with Allscripts to enable the healthcare organization's growing community of independent physicians to access patient visit documentation and other hospital information electronically, in real-time from their offices or remotely via the Internet. Excela-affiliated physicians can leverage this agreement to acquire Allscripts solutions for their practices.

Glen Tullman, Chief Executive Officer of Allscripts, commented, "Virtually everything we do in our daily lives requires access to the right information at the right time, whether its online banking, financial investment decisions, or even traffic conditions. Yet in healthcare we expect physicians to make critical decisions without access to all the information they n
'/>"/>

SOURCE Allscripts
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare
2. World Health Care Congress and ConnextionsHealth Will Host Leadership Summit to Address Member Retention for Health Insurance Plans
3. The Healthcare Communication & Marketing Association Announces June 2009 Conference and IN-AWE and Delta Awards Ceremony
4. Genomic Health Announces Management Changes and New Responsibilities
5. Budgetary Constraints on Health Care Facilities to Affect PACS, RIS, and CVIS Markets
6. Isis Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
7. Cardinal Health Updates FY09 Outlook
8. Digirad Corporation CEO to Present at J.P. Morgan Healthcare Conference in San Francisco
9. Walling Data and AVG Restore Pyramid Healthcare's Efficiency
10. Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show
11. Cost containment focus could have consequences for health care delivery
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 1VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 2VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 3VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 4VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 5CHEENY KUM 3A The Mobile Online Way to Monitor Diabetes 60310 1CHEENY KUM 3A The Mobile Online Way to Monitor Diabetes 60310 2Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 1Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 2